The DPP-4 Inhibitor Linagliptin Improves Cardiac Function in GLP-1 Receptor Knockout Mice with Hypertrophic Heart Failure

被引：0
|
作者：
Batchu, Sri N.
Kabir, Golam
Klein, Thomas
Connelly, Kim A.
机构：
来源：
DIABETES | 2016年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
485-P
引用
收藏
页码：A127 / A127
页数：1
相关论文
共 50 条
  • [21] Global View on Safety and Efficacy of GLP-1 Receptor Agonists and DPP-4 Inhibitors
    Timofte, L.
    Stratmann, B.
    Bojita, M. T.
    Quester, W.
    Tschoepe, D.
    DIABETES STOFFWECHSEL UND HERZ, 2015, 24 (01): : 19 - 27
  • [22] Cardiovascular effects of DPP-4 inhibition: Beyond GLP-1
    Fadini, Gian Paolo
    Avogaro, Angelo
    VASCULAR PHARMACOLOGY, 2011, 55 (1-3) : 10 - 16
  • [23] GLP-1 receptor agonists and DPP-4 inhibitors in the treatment of type 2 diabetes
    Ahrén, B
    Schmitz, O
    HORMONE AND METABOLIC RESEARCH, 2004, 36 (11-12) : 867 - 876
  • [24] Choosing between GLP-1 Receptor Agonists and DPP-4 Inhibitors: A Pharmacological Perspective
    Brown, Dominique Xavier
    Evans, Marc
    JOURNAL OF NUTRITION AND METABOLISM, 2012, 2012
  • [25] The Place of GLP-1–Based Therapy in Diabetes Management: Differences Between DPP-4 Inhibitors and GLP-1 Receptor Agonists
    Dara L. Eckerle Mize
    Marzieh Salehi
    Current Diabetes Reports, 2013, 13 : 307 - 318
  • [26] The DPP-4 Inhibitor Linagliptin Restores β-Cell Function in Human Isolated Islets
    Shah, Payal
    Schumann, Desiree M.
    Ardestani, Amin
    Shu, Luan
    Paroni, Federico
    Kerr-Conte, Julie
    Klein, Thomas
    Maedler, Kathrin
    DIABETES, 2010, 59 : A457 - A457
  • [27] DPP-4 inhibitors vs GLP-1 receptor agonists after failure of metformin monotherapy in type 2 diabetes
    Hernandez Mijares, A.
    AVANCES EN DIABETOLOGIA, 2010, 26 (03): : 200 - 202
  • [28] A dipeptidyl peptidase-4 (DPP-4) inhibitor, linagliptin, attenuates cardiac dysfunction after myocardial infarction independently of DPP-4
    Yamaguchi, Takehiro
    Watanabe, Ayano
    Tanaka, Masako
    Shiota, Masayuki
    Osada-Oka, Mayuko
    Sano, Soichi
    Yoshiyama, Minoru
    Miura, Katsuyuki
    Kitajima, Shojiro
    Matsunaga, Shinji
    Tomita, Shuhei
    Iwao, Hiroshi
    Izumi, Yasukatsu
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2019, 139 (02) : 112 - 119
  • [29] DPP-4 inhibitors vs GLP-1 receptor agonists after failure of metformin monotherapy in type 2 diabetes
    Hernandez Mijares, A.
    AVANCES EN DIABETOLOGIA, 2010, 26 (04): : 270 - 272
  • [30] Defining the Role of GLP-1 in the Enteroinsulinar Axis in Type 2 Diabetes Using DPP-4 Inhibition and GLP-1 Receptor Blockade
    Aulinger, Benedikt A.
    Bedorf, Anne
    Kutscherauer, Gabriele
    de Heer, Jocelyn
    Holst, Jens J.
    Goeke, Burkhard
    Schirra, Joerg
    DIABETES, 2014, 63 (03) : 1079 - 1092
12345